immunotherapy Archives

Esphera SynBio closes seed financing round to advance their lead designer cancer vaccine

Posted on January 7, 2025 (January 7, 2025) by Ricky

January 7, 2025 – FACIT congratulates portfolio company, Esphera SynBio (“Esphera”), on successfully securing seed financing and strategic partners to continue developing bespoke cancer immunotherapies using their proprietary engineered exosome-based platform for improved vaccine efficacy.

FACIT founded Turnstone Biologics debuts on Nasdaq market

Posted on July 21, 2023 (November 1, 2023) by Ricky

July 21, 2023 – FACIT congratulates Turnstone Biologics on the announcement of their upsized initial public offering (IPO) and debut on the Nasdaq market.